560 related articles for article (PubMed ID: 22209898)
1. Nuclear export of proteins and drug resistance in cancer.
Turner JG; Dawson J; Sullivan DM
Biochem Pharmacol; 2012 Apr; 83(8):1021-32. PubMed ID: 22209898
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agents.
Turner JG; Dawson J; Cubitt CL; Baz R; Sullivan DM
Semin Cancer Biol; 2014 Aug; 27():62-73. PubMed ID: 24631834
[TBL] [Abstract][Full Text] [Related]
3. Nucleo-cytoplasmic transport as a therapeutic target of cancer.
Gravina GL; Senapedis W; McCauley D; Baloglu E; Shacham S; Festuccia C
J Hematol Oncol; 2014 Dec; 7():85. PubMed ID: 25476752
[TBL] [Abstract][Full Text] [Related]
4. Human multiple myeloma cells are sensitized to topoisomerase II inhibitors by CRM1 inhibition.
Turner JG; Marchion DC; Dawson JL; Emmons MF; Hazlehurst LA; Washausen P; Sullivan DM
Cancer Res; 2009 Sep; 69(17):6899-905. PubMed ID: 19690141
[TBL] [Abstract][Full Text] [Related]
5. CRM1-mediated nuclear export of proteins and drug resistance in cancer.
Turner JG; Sullivan DM
Curr Med Chem; 2008; 15(26):2648-55. PubMed ID: 18991627
[TBL] [Abstract][Full Text] [Related]
6. CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity.
Sakakibara K; Saito N; Sato T; Suzuki A; Hasegawa Y; Friedman JM; Kufe DW; Vonhoff DD; Iwami T; Kawabe T
Blood; 2011 Oct; 118(14):3922-31. PubMed ID: 21841164
[TBL] [Abstract][Full Text] [Related]
7. Ratjadone and leptomycin B block CRM1-dependent nuclear export by identical mechanisms.
Meissner T; Krause E; Vinkemeier U
FEBS Lett; 2004 Oct; 576(1-2):27-30. PubMed ID: 15474004
[TBL] [Abstract][Full Text] [Related]
8. Novel reversible selective inhibitor of nuclear export shows that CRM1 is a target in colorectal cancer cells.
Niu M; Chong Y; Han Y; Liu X
Cancer Biol Ther; 2015; 16(7):1110-8. PubMed ID: 25996664
[TBL] [Abstract][Full Text] [Related]
9. Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1.
Sun Q; Carrasco YP; Hu Y; Guo X; Mirzaei H; Macmillan J; Chook YM
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1303-8. PubMed ID: 23297231
[TBL] [Abstract][Full Text] [Related]
10. Nuclear targeting of adenovirus type 2 requires CRM1-mediated nuclear export.
Strunze S; Trotman LC; Boucke K; Greber UF
Mol Biol Cell; 2005 Jun; 16(6):2999-3009. PubMed ID: 15814838
[TBL] [Abstract][Full Text] [Related]
11. CRM1-dependent, but not ARE-mediated, nuclear export of IFN-alpha1 mRNA.
Kimura T; Hashimoto I; Nagase T; Fujisawa J
J Cell Sci; 2004 May; 117(Pt 11):2259-70. PubMed ID: 15126627
[TBL] [Abstract][Full Text] [Related]
12. The myxobacterial metabolite ratjadone A inhibits HIV infection by blocking the Rev/CRM1-mediated nuclear export pathway.
Fleta-Soriano E; Martinez JP; Hinkelmann B; Gerth K; Washausen P; Diez J; Frank R; Sasse F; Meyerhans A
Microb Cell Fact; 2014 Jan; 13():17. PubMed ID: 24475978
[TBL] [Abstract][Full Text] [Related]
13. Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) protein.
Ishizawa J; Kojima K; Hail N; Tabe Y; Andreeff M
Pharmacol Ther; 2015 Sep; 153():25-35. PubMed ID: 26048327
[TBL] [Abstract][Full Text] [Related]
14. Biogenesis and nuclear export of ribosomal subunits in higher eukaryotes depend on the CRM1 export pathway.
Thomas F; Kutay U
J Cell Sci; 2003 Jun; 116(Pt 12):2409-19. PubMed ID: 12724356
[TBL] [Abstract][Full Text] [Related]
15. Identification of functional nuclear export sequences in human topoisomerase IIalpha and beta.
Mirski SE; Bielawski JC; Cole SP
Biochem Biophys Res Commun; 2003 Jul; 306(4):905-11. PubMed ID: 12821127
[TBL] [Abstract][Full Text] [Related]
16. Ratjadones inhibit nuclear export by blocking CRM1/exportin 1.
Köster M; Lykke-Andersen S; Elnakady YA; Gerth K; Washausen P; Höfle G; Sasse F; Kjems J; Hauser H
Exp Cell Res; 2003 Jun; 286(2):321-31. PubMed ID: 12749860
[TBL] [Abstract][Full Text] [Related]
17. Atomic basis of CRM1-cargo recognition, release and inhibition.
Fung HY; Chook YM
Semin Cancer Biol; 2014 Aug; 27():52-61. PubMed ID: 24631835
[TBL] [Abstract][Full Text] [Related]
18. Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells.
Etchin J; Sun Q; Kentsis A; Farmer A; Zhang ZC; Sanda T; Mansour MR; Barcelo C; McCauley D; Kauffman M; Shacham S; Christie AL; Kung AL; Rodig SJ; Chook YM; Look AT
Leukemia; 2013 Jan; 27(1):66-74. PubMed ID: 22847027
[TBL] [Abstract][Full Text] [Related]
19. The Cellular Distribution of RanGAP1 Is Regulated by CRM1-Mediated Nuclear Export in Mammalian Cells.
Cha K; Sen P; Raghunayakula S; Zhang XD
PLoS One; 2015; 10(10):e0141309. PubMed ID: 26506250
[TBL] [Abstract][Full Text] [Related]
20. CBS9106-induced CRM1 degradation is mediated by cullin ring ligase activity and the neddylation pathway.
Saito N; Sakakibara K; Sato T; Friedman JM; Kufe DW; VonHoff DD; Kawabe T
Mol Cancer Ther; 2014 Dec; 13(12):3013-23. PubMed ID: 25253782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
